Comparative Pharmacology
Head-to-head clinical analysis: CAMILA versus NOR QD.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CAMILA versus NOR QD.
CAMILA vs NOR-QD
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Progestin-only oral contraceptive. Norethindrone suppresses gonadotropins (primarily LH and FSH), preventing follicular maturation and ovulation. It also increases viscosity of cervical mucus and alters endometrial morphology.
Progestin-only contraceptive; suppresses ovulation and alters cervical mucus and endometrium to inhibit sperm penetration and implantation.
0.35 mg orally once daily at the same time each day without interruption.
0.35 mg orally once daily, taken at the same time each day.
None Documented
None Documented
Terminal elimination half-life: 36 hours (range 20-60 hours); allows once-daily dosing, steady-state achieved by 8 days.
Terminal elimination half-life (norethindrone) is 7-8 hours; clinical effect duration supports once-daily dosing.
Renal: ~40% as unchanged drug and metabolites; biliary/fecal: ~60% as metabolites.
Renal (approximately 30-50% as metabolites, <10% unchanged) and fecal (40-60% via biliary excretion); enterohepatic recirculation contributes to sustained levels.
Category C
Category C
Progestin Contraceptive
Progestin Contraceptive